Larry Ellison’s $7.5 Billion Oracle Sale Plan Lived One Day in Public
A Friday filing showed the Oracle co-founder lining up a sale of as many as 50 million shares. By Saturday he’d dropped it, and the backdrop says plenty about concentrated wealth and borrowing.
By Sean Anees Saifi · Capital Wealth · Published Tuesday, September 15, 2026 · Source: The Wall Street Journal, September 14, 2026 edition (Business & Finance)
Key Points
Larry Ellison scrapped a plan to sell up to $7.5 billion of Oracle stock a day after a filing disclosed it.
The plan, adopted June 22, covered as many as 50 million shares to be sold by Oct. 24; Oracle says none were sold.
A Journal analysis found about 24% of Ellison’s roughly $200 billion net worth pledged as collateral.
Oracle aims to raise up to $50 billion this year for AI data centers, and debt worries helped push its shares down more than 23%.
In 2001, Ellison sold nearly $900 million of Oracle stock just over a month before a nearly 22% slide.
$7.5B
Oracle stock Ellison planned to sell, then didn’t
24%
share of Ellison’s net worth pledged as collateral
23%+
drop in Oracle shares so far this year
$50B
stock and debt Oracle plans to raise this year
Larry Ellison had lined up a sale of as many as 50 million Oracle shares, then reversed course a day after the plan became public. Oracle says none were sold.
In one line: Larry Ellison dropped a $7.5 billion Oracle stock sale a day after it surfaced, a reminder of what rides on a fortune tied heavily to one stock.
Since the 1970s, Larry Ellison has clung to an enormous stake in Oracle (ORCL). On Friday, a securities filing showed he’d lined up one of his biggest share sales yet: as many as 50 million shares, worth about $7.5 billion. By Saturday, he’d scrapped it. Oracle says not one share changed hands under the plan, and that he isn’t planning any other sales. In public, the plan lasted about a day.
No reason, plenty of context
The filing said Ellison adopted the plan on June 22 and aimed to finish selling by Oct. 24. The Journal’s report does not say why he reversed course. Tempting as it is to play armchair psychologist, we’ll pass.
The backdrop is on the record, though. Oracle intends to raise up to $50 billion this year through new stock and debt, money meant for data centers built for an expected AI computing boom. Morgan Stanley (MS) credit analysts think it will need at least $100 billion more across 2027 and the first half of 2028. Debt worries have helped sink the shares more than 23% this year, even as the Nasdaq has climbed more than 13%.
There’s history, too. In January 2001, Ellison sold nearly $900 million of Oracle stock just over a month before the shares fell nearly 22% on weaker-than-expected earnings. A shareholder insider-trading lawsuit followed, and he settled it by agreeing to give $100 million to charity.
Concentration meets collateral
Few people on Earth are richer than Ellison. Few, the Journal suggests, may owe more, and much of his fortune rides on Oracle. The paper’s analysis found about 24% of his roughly $200 billion net worth pledged as collateral — assets promised to lenders to secure loans. He’s pledged more than $40 billion to support his son David Ellison’s hostile bid — an unwelcome takeover offer — for Warner Bros., in a deal worth nearly $80 billion.
Most families won’t pledge $40 billion of anything. But executives and founders paid in company stock know the shape: one holding dominates, and borrowing against it can feel easier than selling. Illustration only: a 23% drop on a $500,000 position wipes out about $115,000, and a loan backed by those shares doesn’t shrink with them.
What It Means For Your Portfolio
Watch — Oracle stays watched, not traded
Watch, don’t trade: the sale’s off, but a fortune tied heavily to one stock, with a big slice pledged as collateral, is a setup worth checking against your own.
Here’s the general planning principle, not advice for anyone in particular: when one stock dominates a household’s net worth, a written plan for trimming it tends to beat deciding in a hurry. Borrowing against that same stock raises the stakes, because the loan stays put while the shares can fall. If your paycheck, savings and loans all lean on one company, that’s one risk counted several times.
Oracle (ORCL) stays on the Capital Wealth watch list, watched but not traded, and this reversal doesn’t change that. Our portfolios also steer clear of leveraged speculation, and nothing new gets bought ahead of Wednesday’s Fed decision. Rain doesn’t send a calendar invite, so the umbrella has to be ready first; bring a statement, and fifteen minutes will show where your own concentration sits.
